张超
-
副教授
- 主要任职:副教授
- 性别:女
- 毕业院校:山东大学
- 学历:研究生(博士后)
- 学位:理学博士学位
- 在职信息:在职
- 所在单位:基础医学院
- 入职时间: 2000-06-01
- 办公地点:山东大学基础医学院实验核医学研究所
- 联系方式:zhangchao@sdu.edu.cn
访问量:
-
[1]
.
Evaluation of CD93hi macrophage on atherosclerosis through dynamic cells adoptive transfer.
ARABIAN JOURNAL OF CHEMISTRY,
16,
2023.
-
[2]
.
Evaluation of a novel EphA2 targeting peptide for triple negative breast cancer based on radionuclid.
ARABIAN JOURNAL OF CHEMISTRY,
15,
2022.
-
[3]
.
Evaluation of CD93hi macrophage on atherosclerosis through dynamic cells adoptive transfer.
ARABIAN JOURNAL OF CHEMISTRY,
16,
2023.
-
[4]
梁婷.
Evaluation of I-131-anti-MIF mAb as a reporter for allograft rejection.
CLINICAL IMMUNOLOGY,
139,
40-47,
2011.
-
[5]
Zhan, Yang.
Down-regulating cyclin-dependent kinase 9 of alloreactive CD4(+) T cells prolongs allograft survival.
Oncotarget,
7,
24983-24994,
2016.
-
[6]
苏晨.
CD93 in macrophages: A novel target for atherosclerotic plaque imaging?.
journal of cellular and molecular medicine,
26,
2152,
2022.
-
[7]
刘伟伟.
Radioimmunoimaging of I-125-labeled anti-CD93 monoclonal antibodies in a xenograft model of non-smal.
ONCOLOGY LETTERS,
18,
6413,
2019.
-
[8]
屈昌秀.
Ligand recognition, unconventional activation, and G protein coupling of the prostaglandin E-2 recep.
科学前沿,
7,
2021.
-
[9]
肖鹏.
Ligand recognition and allosteric regulation of DRD1-Gs signaling complexes.
细胞,
184,
943,
2021.
-
[10]
姜文.
Down-Regulation of Toll-Like Receptor 5 (TLR5) Increased VEGFR Expression in Triple Negative Breast .
FRONTIERS IN ONCOLOGY,
11,
2021.
-
[11]
侯桂华.
Down-Regulation of Toll-Like Receptor 5 (TLR5) Increased VEGFR Expression in Triple Negative Breast .
FRONTIERS IN ONCOLOGY,
2021.
-
[12]
赵姗姗.
IL-27R alpha: A Novel Molecular Imaging Marker for Allograft Rejection.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES ,
21,
2020.
-
[13]
石岱.
TLR5 is a new reporter for triple-negative breast cancer indicated by radioimmunoimaging and fluores.
journal of cellular and molecular medicine,
23,
8305,
2019.
-
[14]
赵姗姗.
IL-27 R alpha(+)cells promoted allorejection via enhancing STAT1/3/5 phosphorylation.
journal of cellular and molecular medicine,
24,
10756,
2020.
-
[15]
宋静 , 梁婷 and 侯桂华.
Alternatively expressed genes identified in the CD4+ T cells of allograft rejection mice..
Cell Transplant.,
20,
333,
2011.
-
[16]
侯桂华.
炎症显像剂99Tcm-lomefloxacin的制备及在炎症小鼠模型体内生物学分布.
《中华核医学杂志》,
29,
406,
2009.
-
[17]
梁婷 , 宋静 and 侯桂华.
Toll样受体4和巨噬细胞移动抑制因子对血管内皮细胞生物活性的影响.
细胞与分子免疫学杂志,
26,
175,
2010.
-
[18]
张超 , 梁婷 , 侯桂华 and 石岱.
TLR5 is a new reporter for triple‐negative breast cancer indicated by radioimmunoimaging and fluor.
Journal of Cellular and Molecular Medicine,
23,
8305,
2019.
-
[19]
张超 , 曹慧 , 梁婷 , 侯桂华 and 刘伟伟.
Radioimmunoimaging of 125I?labeled anti?CD93 monoclonal antibodies in a xenograft model of non?s.
ONCOL LETT,
18,
6413,
2019.
-
[20]
张超 , 梁婷 , 侯桂华 and 石岱.
TLR5: A prognostic and monitoring indicator for triple-negative breast cancer.
《Cell Death and Disease》,
10,
954,
2019.